PAVIA ANNUAL MEETING 2018, TANZANIA
PAVIA BLENDED TRAINING IN COORDINATION WITH VERONA TEAM
PAVIA ANNUAL CONSORTIUM MEETING 2019, ETHIOPIA
3rd PAVIA training
The PAVIA project aims to strengthen pharmacovigilance (PV) in four African countries: Ethiopia, Eswatini, Nigeria, and Tanzania. To achieve this aim, collaborative support will be harnessed across several institutions in Europe and Africa.
Workpackage
WP2 is on Policy, Laws, and Regulations. In this WP, we will support the target countries to address the relevant policies… more
WP3 is about Data collection and Signal Detection, including Data Management Measures. In this WP, we work… more
WP4 deals with Monitoring and Evaluation. The objective of this WP is to measure the impact of our PV activities in a… more
WP5 entails System, Structure, and Stakeholder Measures. This WP aims to strengthen organizational structures… more
Our Achievements
-
Tanzania Achievements
in NewsTANZANIA Training Staff from The Tanzania Medicines and Medical Devices Authority (TMDA) a...
-
Ethiopia Achievements
in NewsSupportive Supervision was conducted on general pharmacovigilance and Active TB-Drugs Safe...
-
1ST MEETING OF aDSM CAUSALITY ASSESSMENT COMMITTEE AT KNCV CONFERENCE HALL 24TH – 25TH JUNE 2021
in News1ST MEETING OF aDSM CAUSALITY ASSESSMENT COMMITTEE AT KNCV CONFERENCE HALL 24TH – 25TH J...
-
PAVIA at 50th Union Conference
in ConferenceSymposium session proposal: Sustainable models for strengthening pharmacovigilance of TB m...
-
Safety and reporting of adverse events of new anti-tuberculosis drug regimens in Sub-Sahara Africa: Analysis of individual case safety reports.
in News, Report NigeriaThe main aim is to report the safety and management of adverse drugs reactions associated ...
-
What does the PAVIA team say
The Following People are Part of PAVIA
"Workpackage 5 lead"
Blandina Theophil Mmbaga- is a paediatrician at Kilimanjaro Christian Medical Centre (KCMC), Director of the Kilimanjaro Clinical Research Institute (KCRI), senior... read more
"Workpackage 3 lead"
Linda Härmark studied pharmacy at the University of Uppsala, Sweden. After graduation she relocated to the Netherlands where she joined the Netherlands... read more
"Workpackage 2 lead"
Professor Ambrose O. Isah graduated from the University of Ibadan Medical School in 1979 and had his residency training in Internal Medicine at the University of Benin Teaching Hospital... read more
"Steering Committee Member"
He is the Managing Director/Chief Operating Officer (MD/COO), of the Institute of Human Virology Nigeria and also an Ex-officio Director of the Board. He is responsible for the... read more
"Steering Committee Member"
She graduated in 2002 in Master of Science Chemistry and Pharmaceutical Technologies (Grade A cum laude). Since 2003 up to now she is working with a research contract at the... read more
"Steering Committee Member"
She is responsible for giving policy direction to the National Pharmaceutical Services of the Kingdom of Eswatini, Review of Pharmaceutical Legislations and Regulations, Development ... read more
Our Team
PV Coordinator: Eswatini
Alemayehu Duga
Workpackage 2 lead
Ambrose Isah
Workpackage 5 lead
Blandina Mmbaga
Overall project lead
Frank Cobelens
Assistant Coordinator:PAVIA project
Henry Tumwijukye
PV Coordinator: Ethiopia
Kassech Sintayehu
Workpackage 3 lead
Linda Härmark
Project manager
Nina Schat
PV Coordinator: Tanzania
Seth Kisenge
Our Participants in PAVIA Project
Following are participants involved in PAVIA Project
News and Events
Tanzania Achievements
TANZANIA Training Staff from The Tanzania Medicines and Medical Devices Authority (TMDA) attended the third (3rd) PAVIA training which was conducted from 14-18 June, 2021. The training was facilitated by the Lareb, the European Medicine Agency (EMA) and FDA Ghana. The training aimed at building... ...
Ethiopia Achievements
Supportive Supervision was conducted on general pharmacovigilance and Active TB-Drugs Safety Monitoring and Management (aDSM) Ethiopia has implemented different regimens for treatment of Multi Drug Resistant Tuberculosis (MDR-TB) and introduced new anti TB drugs (bedaquiline (Bdq) and delamanid (Dlm) and repurposed drugs (clofazimine and linezolid)... ...
1ST MEETING OF aDSM CAUSALITY ASSESSMENT COMMITTEE AT KNCV CONFERENCE HALL 24TH – 25TH JUNE 2021
1ST MEETING OF aDSM CAUSALITY ASSESSMENT COMMITTEE AT KNCV CONFERENCE HALL 24TH – 25TH JUNE 2021 Background Active Drug Safety Monitoring (aDSM) is an active form of pharmacovigilance recommended by the WHO for active and systematic clinical and laboratory assessment of patients on treatment with... ...
PAVIA at 50th Union Conference
Symposium session proposal: Sustainable models for strengthening pharmacovigilance of TB medicines and diagnostics: global and regional perspectives and country examples. . . ...